- Dulaglutide and Incident Atrial Fibrillation or Flutter in patients with type 2 Diabetes; a post-hoc analysis from the REWIND Randomized Trial2022 | Publication without faculty affiliation
- Agonization of GLP-1 in cardiology2020 | Faculty of Medicine in Pilsen
- Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial2017 | First Faculty of Medicine
- CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes2023 | First Faculty of Medicine
- Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes2016 | Second Faculty of Medicine
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial2019 | Publication without faculty affiliation
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial2019 | Publication without faculty affiliation